NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

CALGARY, AB / ACCESSWIRE / June 25, 2020 / Softlab9 Software Solutions Inc. (CSE:SOFT)(Frankfurt:APO2)(OTC PINK:SOFSF)("SOFT" or the "Company") is pleased to announce that its target company, Clean Go Green Go, Inc., has launched a new product based off its patented disinfectant.

The new product is a vaporized version of the Clean Go Green Go disinfectant that is now being used as a more efficient way to disinfect vehicles. The Non-toxic disinfectant is being used as a fog to clean the nooks and crannies of Taxies in Calgary. This method can be used to clean vehicles, aircrafts, gyms, office spaces, commercial areas, hospitals, and many more potential applications.

Using this eco-friendly and non-toxic patented disinfectant as a fog is an effective way to sterilize all hard and soft surfaces as well as any airborne contaminants.

Anthony Sarvucci, CEO of Clean Go Green Go said, "The launch of this new product line will open up a new revenue streams for our company as well create a new line of defence against viral and bacterial agents including the human coronavirus. Clean Go's vaporizing disinfectant product has been used for public transportation and for public spaces and can be expanded to be used in airplanes, commercial properties, malls, and offices spaces. We are hoping that through our innovation and product line, we are helping curb the spread of the current COVID-19 pandemic."

The partners at "The Wash Auto Spa" in Calgary (https://www.thewashautospa.com/) have been using a white labeled of Clean Go Green Go's product line for fogging and disinfecting for several months with excellent results.

Jeff Minton, Owner of The Wash Auto Spa located in Downtown Calgary, Alberta said: "We have been using the TNT Complete line, a private label of CleanGo GreenGo now for 4 months and the Cleaning and Sanitizing Power of this product is one of a kind. Through our Fogging and detailing service, we have been Sanitizing Taxi Cabs, Rental Cars and Commercial Vehicles. Clean Go's non-toxic product have given our customers peace of mind knowing that their vehicle is sterilized once it leaves one of our locations."

The proposed transaction to acquire Clean Go Green Go was announced on May 21st, 2020 and is still pending closing and signing of a definitive agreement.

More information about CleanGo GreenGo and inquiries about the new "Fogging product line" can be found at https://CleanGoGreenGo.com

Clean Go Green Go Products:

All CleanGo GreenGo products are Non-Toxic, Green and Biodegradable. CleanGo GreenGo products are safe around your Children and Pets as well as Safe for the Environment.

About "Clean Go Green Go"

CleanGo GreenGo Inc. is an FDA and Health Canada approved a Canadian/US Manufacturer of Green, Non-Toxic and Biodegradable suite of cleaning products for industrial, commercial and consumer markets. CleanGo GreenGo, also Manufactures Hand Sanitizer Gel which is sold throughout the USA and Canada. Clean Go's products have been tested in the USA in 2015 to kill the human coronavirus. CleanGo's products are sold in Various Online Platforms, including Amazon, as well as through distribution into retail, wholesale, and government agencies. CleanGo GreenGo utilizes a Patent Pending IP. the Patent was filed with United States Patent and Trademark Office in February 2020 and currently holds a current Patent Pending Status.

About SoftLab9.:

SoftLab9 is an incubator specializing in developing, launching, acquiring, and vertically integrating companies. They foster a portfolio of assets internally while providing engineering, capital, executive management, and industry experience. The Company brings together innovative ideas based on solid foundations and experienced teams to build leading companies. For further information please contact:

Rahim Mohamed
Chief Executive Officer
Phone: (403) 605-9429
RM@softlab9.com
https://www.soft-lab9.com/

Paul Searle
Corporate Communications
Citygate Capital Corp
Phone: (778) 240-7724
psearle@citygatecap.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Cautionary Note:

The Company is not making any express or implied claims that Clean Go Green Go or any other product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time. Do not drink or consume any of the products at any time. Follow the instructions on the bottles. The products mentioned are meant to be used on surfaces and hands to sanitize to protect against bacteria and Viruses. Clean Go Green Go is not a cure, nor does it imply to be a cure for COVID-19.

Forward-looking Information

This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements in this presentation that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations, and orientations regarding the future, including without limitation statements related to the completion of the Private Placement and the use of the proceeds therefrom, and the Company's prospect of success in executing its proposed plans, including its plans to complete the acquisition of CleanGo and the prospects for CleanGo's business. Forward-looking statements can often be identified by words such as "will", "plans", "expects", "may", "intends", "anticipates", "believes", proposes" or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements are based on certain assumptions by management regarding the Company, including, without limitation, investor interest in the Private Placement, and the Company's ability to acquire CleanGo and obtain required regulatory approvals and the timing thereof. Actual results could differ from those projected in any forward-looking statements due to numerous factors including, risks and uncertainties relating to the inability of the Company, to, among other things, obtain any required governmental, regulatory or stock exchange approvals, permits, consents or authorizations required to execute its proposed business plans, and obtain the financing required to carry out its planned future activities. Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the Company's operations may also adversely affect the future results or performance of the Company. The Company can provide no guarantee that it will be successful in completing the Private Placement or completing the acquisition of CleanGo. Investors are cautioned that forward looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forward-looking statements included in this news release are made as of the date hereof and the Company does not intend to update or revise any forward-looking statements, except as expressly required by law.

SOURCE: Softlab9 Software Solutions Inc.

ReleaseID: 595220

PENTICTON, BC / ACCESSWIRE / June 25, 2020 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST) is pleased to announce that further to the Company's press release dated June 18, 2020, the Company has closed a private placement financing with the issuance of 1,992,727 common shares at a price of $0.05 per common share for aggregate proceeds of $99,636.37. The private placement was subscribed by one investee Summit Bancorp. The proceeds from the private placement will be used for general corporate purposes. The common shares issued pursuant to this private placement have been approved by TSX Venture Exchange and are subject to a statutory four-month hold period in accordance with applicable securities laws.

Further to the Company's June 15, 2020 press release, the Company is also pleased to announce the closing of the previously disclosed shares for debt transactions whereby the Company issued 6,007,270 common shares at a price of CDN $0.05 per common share to certain arm's length and non-arm's length individuals and service providers for settlement of a significant portion owing by the Company in respect of various services rendered, including but not limited to consulting, accounting and legal, and for settlement of loans and/or advances provided to the Company. The transactions with non-arm's length parties were in the normal course of operations and were measured at the agreed upon amounts, which is the amount of consideration established and agreed to by the related parties.

All of the common shares issued pursuant to the shares for debt transactions have been approved by the TSX Venture Exchange approval and have a statutory four-month hold period in accordance with applicable securities laws.

About EastWest Bioscience Group

EastWest Bioscience is a vertically integrated wellness company with the infrastructure to become a global giant in the Hemp & CBD consumer health market. Since it was founded in 2016, EastWest continues to grow as a high-quality producer, manufacturer and distributor of multiple lines of premium health and hemp products. EastWest currently has more than 200+ NPN's in its stable of products.

EastWest's Hemp consumer product lines are divided into four distinct brands: 1) Natural Advancement – natural biopharmaceutical health supplements; 2) Earth's Menu – all-natural hemp superfoods; 3) Natural Pet Science – pet food and pet supplements; and 4) ChanvreHemp – all-natural health and beauty products.

In Canada, EastWest has a 34,000 Sq. Ft, Health Canada-licensed, GMP (Good Manufacturing Practices) – certified manufacturing facility and produces premium nutraceutical brands, offering natural products for a preventive care lifestyle. EastWest and Benchmark Botanicals (BBT-CSE) also have a Joint Venture Intent to accelerate acquisition of Processor, Analytical and Research and Development licenses under the Cannabis Act in EastWest's Penticton facility. These three classes of the Cannabis Act license will allow Benchmark and EastWest to build out an extensive extraction, laboratory, and research facility at EastWest's Health Canada Certified facility.

In the USA, EastWest USA has a Joint Venture with Azema Sciences, securing for EastWest first rights on Azema's output of bulk CBD and finished CBD products manufactured, and which are ready for sale in the USA and globally. EastWest Science USA ("EastWest USA"), EastWest's US operating division, will be the preferred distributor for Azema's finished goods. These finished products will include CBD creams, tinctures and salves which are products not currently in EastWest's catalogue. Additionally, EastWest will have first right of refusal to all potential opportunities relating to Azema's Kentucky based CBD processing facility. EastWest currently has TSX Approval for sale of its consumer products in 21 US States.

ON BEHALF OF THE BOARD OF DIRECTORS
EASTWEST BIOSCIENCE GROUP

"Rodney Gelineau"
Co-Founder, Chief Executive Officer and Director

TSXV – Symbol: EAST

Company Website: www.eastwestbioscience.com
Contact: Rodney Gelineau on 1-800-409-1930 or investors@eastwestscience.com.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the terms and conditions of the Acquisition. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: EastWest Bioscience Inc.

ReleaseID: 595222

North American Cannabis and Hemp Executive to develop and implement North American launch for Love Hemp

LONDON, UK / ACCESSWIRE / June 25, 2020 / World High Life Plc (AQSE:LIFE)(OTCQB:WRHLF) is pleased to announce the appointment of international Hemp/CBD executive, Mr. Ross Westbrook, as Advisor for North American growth and operations as the Company prepares to build upon its UK success.

In preparation for the launch of Love Hemp products in North American markets, World High Life has appointed Mr. Ross Westbrook to plan and implement the Company's strategy and operations for expansion. Ross Westbrook is recognized a leader in the Hemp/CBD retail space in particular, processing and marketing CBD products for nationally recognized brands such as Lazarus Naturals and Select (Social) CBD, Panacea Life Sciences, Luxe CBD, Infinite CBD, Pure Hemp Botanicals, Pharm CBD, Wink-wink and Paradise Candy.

Ross Westbrook Appointment Highlights

Mr. Ross Westbrook Appointed as Advisor for North American Growth and Operations
Recently served a term as Treasurer of the California Hemp Council – Sacramento, Ca.
CEO of Canamo Genetics
Founding member of Hemptown USA, and served as COO
Regional Sales Executive and Distributor for Panacea Life Sciences
Purveyor of CBD products at Transcend Canna in California carrying 11 product lines
Founded eFruit in 2011 and sold to Private Equity Group in 2015 with $20+ million in sales worldwide
Founded Primavera Marketing and served as their President for 22 years selling the company in 2010 with sales in excess of $200 million worldwide
Masters in International Business

Mr. Westbrook has more than 35 years in farming and marketing specialized agriculture-based items world-wide. He has implemented specialized marketing campaigns over the years to Costco in both the United States and Asia, and to Safeway, Kroger, Walmart and Whole Foods. He also has extensive experience marketing globally to Aeon, Lotte, Shinshegae, Marks & Spencer, Waitrose, Sainsburys, Alibaba derivatives, Coles, Woolworths and Cold Storage. Ross has exported or sold products to more than 33 different countries and has opened and managed sales offices in Hong Kong, Tokyo and Santiago, Chile.

"The Love Hemp Brand and product line continue to grow in the UK with strong consumer support, and our team has recognized the significant opportunity that exists to expand to North America as the next step in achieving our objective of making Love Hemp a global brand," said Mr. David Stadnyk, World High Life Founder and CEO. "We are thrilled that Ross is now part of the World High Life team, his knowledge and experience in this industry combined with his network allow us to advance our business plan expediently, establishing a strong foundation for success going forward."

"My experience in the industry has informed my belief that novel cannabinoids will be combined with traditional holistic plant materials that have been used medicinally for centuries," said Mr. Westbrook. "The minute that I realized both David Stadnyk, WHL Founder and CEO, and Tony Calamita, Founder and CEO of Love Hemp, were of a similar mindset I knew that together, we had a unique and exciting opportunity to benefit people searching for innovative and effective health and wellness solutions. The addition of Love Hemp's recently appointed Scientific Advisors further cemented the commitment to our shared vision. Every stop along my Hemp/CBD journey has been a stepping-stone to reach World High Life."

For further information please contact:

David Stadnyk
Founder & CEO
North America: 1 (236) 521-7211
North America toll-free: 1 (888) 616-WRHLF (9745)
+44 (0) 7926 397 675
info@worldhighlife.uk

AQSE Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
ma@peterhousecap.com
af@peterhousecap.com

Financial PR
Camilla Horsfall/Megan Ray
Blytheweigh
+44 (0) 20 7138 3224
Camilla.horsfall@blytheweigh.com
Megan.Ray@blytheweigh.com

For more information on World High Life please visit: www.worldhighlife.uk

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward Looking Information

We seek safe harbour. Some statements contained in this news release are "forward looking information" within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes" or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management's current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.

SOURCE: World High Life PLC

ReleaseID: 595166

VANCOUVER, BC / ACCESSWIRE / June 25, 2020 / GREAT ATLANTIC RESOURCES CORP. (TSXV.GR)(FRA:PH01) (the "Company" or "Great Atlantic") is pleased to announce it is commenced the 2020 exploration program at its Keymet Precious Metal – Base Metal Property, located in northeast New Brunswick. The 2020 program will focus on gold exploration in the southwest to central regions of the property. The Company has identified exploration targets in these regions based on historical work. Reported historic highlights in these regions include a reported trench chip sample of 2.5 grams / tonne (g/t) gold over 6.1 meters length, rock grab samples up to 4.3 g/t gold and soil samples of 217 and 325 parts per billion (ppb).

The Company has commenced prospecting and rock – soil geochemical sampling in the southwest to central regions of the Keymet Property to define trenching and drilling targets. Geophysical surveys are also planned for these regions during 2020 to further define exploration targets. Company management have evaluated historical public records and have identified targets for focused 2020 gold exploration in these regions of the property. Reported historical highlights for these regions include:

2.5 grams / tonne (g/t) gold over 6.1 meters and 1.9 g/t gold over 1.5 metes in historical trench (1980s).
3.3 g/t gold over 0.60 meters in historical trench and 4.3 g/t gold in grab sample (Alcida East Gold occurrence).
Gold soil geochemical anomalies were reported during 2005, including reported high values for gold of 217 and 325 ppb.

Three gold deposits with reported mineral resources are reported west of the southwest region of the Keymet Property within adjacent mineral claims. Great Atlantic has no interest in these adjacent mineral claims. These deposits, referred to as the West Gabbro Zone, Discovery Zone and South Gold Zone, are reported within 2 kilometers of the Keymet Property southwest boundary.

Micon International Limited reported 43-101 compliant mineral resources for the West Gabbro Zone (WGZ), South Gold Zone (SGZ) and Discovery Zone (DZ) in Technical Report on the Mineral Resource Estimate for the Elmtree Gold Property (Effective Date: 4 March 2011) for CNRP Mining Inc. and Gorilla Resources Corp. The reported resources include:

WGZ: Indicated Resources: 1,611,000 tonnes @ 1.91 g/t gold
WGZ Inferred Resources: 2,053,000 tonnes @ 1.67 g/t gold
SGZ: Inferred Resources: 2,237,000 tonnes @ 0.74 g/t gold
DZ: Inferred Resources: 741,000 tonnes @ 1.18 g/t gold

As reported by Micon International Limited, the resources were estimated using a three-dimensional block modelling approach. For each mineralized zone, wireframe models were built up from intersected geologic limits. Grade interpolation for the WGZ was conducted using the inverse distance cubed technique while interpolations for the DZ and SGZ were conducted using the nearest neighbour technique due to limited drill hole information. The cut-off grade used was 0.5 g/t gold.

Readers are warned that mineralization at the West Gabbro Zone, South Gold Zone and Discovery Zone on adjacent mineral claims west of the Company's Kemet Property is not necessarily indicative of mineralization on the Keymet Property.

Great Atlantic is also planning exploration during 2020 in the northwest region of the Keymet Property with the focus being gold. Since acquiring the property, the Company has discovered gold bearing float and gold in bedrock (in drill holes and trenches) in this region of the property as well as veins containing high grade zinc, lead, copper and / or silver (see news releases on the Company's website). This included high grade gold in one boulder sample, which returned 51 g/t gold. Planned work in the northwest region of the property include prospecting, rock – soil geochemical sampling and geophysical surveys to define trenching and drilling targets. The southwest – central regions will be the main focus during 2020.

The Keymet Property hosts the historic Keymet Mine, located in the northwest region of the property. The Keymet Mine operated during the mid-1950s, producing copper, lead, zinc and silver. Production at this mine was terminated due to a fire at the site.

Readers are warned that historical records referred to in this News Release have been examined but not verified by a Qualified Person. Further work is required to verify that historical records referred to in this News Release are accurate.

David Martin, P.Geo., a Qualified Person as defined by NI 43-101 and VP Exploration for Great Atlantic, is responsible for the technical information contained in this News Release.

Historic Keymet Mine (1950s)

Access to the Keymet Property is excellent with paved roads transecting the property, including a provincial highway. The property covers an area of approximately 3,400 hectares and is 100% owned by the Company.

On Behalf of the Board of Directors

"Christopher R Anderson"

Mr. Christopher R. Anderson "Always be positive, strive for solutions, and never give up"
President CEO Director
604-488-3900 – Dir

Investor Relations:
Please call 604-488-3900

About Great Atlantic Resources Corp.: Great Atlantic Resources Corp. is a Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Tungsten and Gold.

This press release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address future exploration drilling, exploration activities and events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include exploitation and exploration successes, continued availability of financing, and general economic, market or business conditions.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Great Atlantic Resources Corp.

ReleaseID: 595191

Texas-based Insurance Administrator Will Offer Auto Insurance on PowerBand's Virtual Platform

VANCOUVER, BC / ACCESSWIRE / June 25, 2020 / PowerBand Solutions Inc. (TSXV:PBX) (OTCQB:PWWBF) (Frankfurt:1ZVA) ("PowerBand", "PBX" or the "Company") is pleased to announce that its subsidiary, PowerBand Solutions US Inc. ("PowerBand US"), has closed on its convertible debenture financing (see news release dated March 2, 2020) and that Texas-based D&P Holdings, Inc. ("D&P") will immediately convert USD $6 million of PowerBand US debentures into a direct investment in the Company's US and Canadian financing and leasing divisions.

The investment comes at the time PowerBand is set to begin lease originations for vehicles in the United States using its virtual transaction system, which will enable consumers to use their smart phones, tablets and computers to acquire and finance electric and non-electric vehicles, as easily as buying a product on Amazon.

"We have seen the PowerBand transaction platform in action and we are confident it will be widely used by both consumers and auto dealers, who are increasingly looking to carry out their automotive transactions on a digital transaction platform," said D&P CEO John Armstrong. "We are converting our debentures into an ownership stake because we are confident PowerBand's transaction platform will revolutionize the industry, allowing people to buy, sell, lease, trade and finance a vehicle from any location using their smart phones."

D&P is one of the United States' largest administrators of automotive warranty and insurance products, directly working with more than 850 dealerships in all 50 states. It is the managing general agency for The Hanover Insurance Group, which has a $3.8-billlion market valuation. To date, D&P has invested USD $6 million in debentures in PowerBand US.

"D&P and their team are highly respected leaders in the automotive retail and insurance sectors – we welcome their decision to deepen their partnership with us. I want to thank John Armstrong for bringing his partners and national network of dealerships to PowerBand, a resource that will ensure the imminent launch of PowerBand's transaction platform will be a great success," said PowerBand CEO Kelly Jennings. "D&P will also add more value to PowerBand by offering consumers and dealers automotive insurance products directly on the PowerBand transaction platform, a major convenience for consumers."

PowerBand's first lease originations are set to begin on the leasing platform operated by MUSA Holdings, LLC ("MUSA"), which PowerBand acquired a 60 per cent share of in July 2019. Founded in 2016, MUSA's innovative transaction platform provides dealers and consumers with the most advanced leasing options in the industry. MUSA takes applications, calculates leases, auto-decisions applications, provides approvals back to dealer partners and prefills lease contracts accurately. Approvals can occur in seconds. As a result of its proprietary technology, MUSA was awarded a contract by Tesla Motors to become a national leasing partner in 2018.

D&P has been granted exclusive global rights to act as administrator for new insurance products being sold globally through PowerBand's transaction platform. These include administrating all requested and approved vehicle services contracts, auto warranty products, guaranteed asset protection, down payment protection, excess wear and tear, key replacement, windshield replacement, tire and wheel, ETCH/anti-theft, lease wrap, and all ancillary products.

Under the recent agreement, D&P's debentures will convert into a 9% ownership stake in both PowerBand US and the Company's Canadian financing and leasing division, DRIVRZ Financial Inc.

About PowerBand Solutions Inc.

PowerBand Solutions Inc., listed on the TSX Venture Exchange and the OTCQB markets, is a fintech provider disrupting the automotive industry. PowerBand's integrated, cloud-based transaction platform facilitates transactions amongst consumers, dealers, funders and manufacturers (OEMs). It enables them to buy, sell, trade, finance, and lease new and used, electric- and non-electric vehicles, on smart phones or any other online digital devices, from any location. PowerBand's transaction platform – being trademarked under DRIVRZ – is being made available across North American and global markets.

For further information, please contact:

Richard Goldman, VP Corporate Development
P: 1-866-768-7653
rgoldman@powerbandsolutions.com

FORWARD-LOOKING STATEMENTS

This news release contains forward-looking statements relating to the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding future plans and objectives of the Company, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, we cannot guarantee that any forward-looking statement will materialize, and the reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as at the date of this news release, and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by Canadian securities law.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws, unless an exemption from such registration is available.

SOURCE: PowerBand Solutions Inc.

ReleaseID: 595215

Published Articles Suggest the Global Market for Rituximab Biosimilars Could Potentially be over $1 Billion Per Year
Royalty Stream Relates to Agreement Acquired in Aptevo Spin-off from Emergent BioSolutions

SEATTLE, WA / ACCESSWIRE / June 25, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it will receive a royalty from Pfizer related to sales of a rituximab biosimilar product, RUXIENCE® (Rituximab-pvvr), which was approved by the U.S. Food and Drug Administration in July 2019 and launched by Pfizer in the United States and Japan in early 2020.

"We are pleased to be receiving this first royalty payment from Pfizer and look forward to future quarterly payments, all of which will contribute non-dilutive funding to support our organization," said Marvin L. White, President and Chief Executive Officer. "This funding will help to support the advancement of our novel ADAPTIR™ bispecific antibody platform and more specifically, our lead ADAPTIR bispecific candidate, APVO436, which is progressing in a Phase 1/1b clinical study for the treatment of acute myeloid leukemia. Dosing in cohort 6 of the study is currently underway. We look forward to providing an update on this clinical program as additional data are available."

The payment from Pfizer relates to an agreement acquired by Aptevo as part of its spin-off from Emergent BioSolutions in 2016, which applies a fixed royalty rate in the low single digits on net sales in the United States, European Union, and Japan. The agreement was originally executed by Trubion Pharmaceuticals (which was subsequently acquired by Emergent BioSolutions Inc.,) and Wyeth (a wholly-owned subsidiary of Pfizer). The royalty term runs until the seventh anniversary of the first commercial sale of the CD20 biosimilar. Royalties payments to Aptevo are due within 60 days after the end of each quarter.

RUXIENCE is a biosimilar of Biogen's RITUXAN. In the US, RUXIENCE is approved for treatment of Non-Hodgkin's Lymphoma (alone or with other chemotherapy medicines), Chronic Lymphocytic Leukemia (with the chemotherapy medicines fludarabine and cyclophosphamide), and Granulomatosis with Polyangiitis and Microscopic Polyangiitis (with glucocorticoids). The product is also approved for use in Japan and received marketing authorization in the European Union in April 2020.

Additional information can be found in the Current Report on Form 8-K filed by Aptevo on June 25, 2020.

RUXIENCE is a trademark of Pfizer; RITUXAN is a trademark of Biogen.

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603 were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer. For more information, please visit www.aptevotherapeutics.com

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including, without limitation, statements regarding potential milestone payments, Aptevo's outlook, financial performance or financial condition, estimated cash burn, Aptevo's technology and related pipeline, collaboration and partnership opportunities, milestones, and any other statements containing the words "believes," "expects," "anticipates," "intends," "plans," "forecasts," "estimates," "will" and similar expressions are forward-looking statements. These forward-looking statements are based on Aptevo's current intentions, beliefs and expectations regarding future events. Aptevo cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from Aptevo's expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, Aptevo does not undertake to update any forward-looking statement to reflect new information, events or circumstances.

There are a number of important factors that could cause Aptevo's actual results to differ materially from those indicated by such forward-looking statements, including a deterioration in Aptevo's business or prospects; adverse developments in research and development; adverse developments in the U.S. or global capital markets, credit markets or economies generally; and changes in regulatory, social and political conditions. Additional risks and factors that may affect results are set forth in Aptevo's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as filed on March 25, 2020 and its subsequent reports on Form 10-Q and current reports on Form 8-K. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from Aptevo's expectations in any forward-looking statement.

CONTACT:
Aptevo Therapeutics
Stacey Jurchison
Senior Director, Investor Relations and Corporate Communications
+1 206-859-6628
JurchisonS@apvo.com

SOURCE: Aptevo Therapeutics

ReleaseID: 595169

BURBANK, CA / ACCESSWIRE / June 25, 2020 / Quanta Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, announced the launch of molequle, a new skincare brand initially featuring masks and under eye patches. The products, made with all-natural ingredients and featuring Quanta's polarization technology, are slated to debut on Amazon's retail platform this summer. Other e-tailing outlets are expected to launch later in 2020.

Eric Rice, Chief Executive Officer of Quanta commented, "Quanta branded and licensed products feature polarized ingredients that have proven to significantly augment the therapeutic and overall health benefits in many consumer products. In much the same way we introduced consumers to these benefits through our enhanced Quanta CBD Muscle Rub, molequle will offer a broader set of consumers similar skincare benefits via Amazon and other e-tail platforms."

Purposely designed as an e-tail brand, molequle (www.molequleskincare.com) will be sold on Amazon.com and other e-tail platform and comprises seven SKU's: four full face masks and three eye patches – carrying pithy, fun names like "Baggage Handler" and "Magic Mushroom Moisturizing Mask" aimed at the Glossier consumer (younger Millennials and Gen Z). A pack of three full-face masks will initially retail for $24.99 and a pack of two eye patches retails for $14.99.

The facial mask category, globally, has grown at a double-digit clip since 2010, and is expected to continue to grow in excess of 10% per year to an estimated $11.4 billion globally by 2025 according to Adroit, with sheet masks accounting for 36% of this market. Quanta's demonstrated technology delivers enhanced results as proven by recent polarization studies on Vitamin A (Retinol), Topical Vitamin C and Growth Factor – see here

"Quanta remains a technology provider and this effort illustrates how co-branding with us looks," added Rice. "Currently we sell through physicians and select retail outlets and mostly to a male customer base. However, beauty products sold on Amazon reach a more female-dominated consumer buying base and we are excited to drive awareness of the benefits of polarization through sales to all those who want the best products that promote a healthier lifestyle on this exciting new platform."

About Quanta:

Quanta, Inc. ("Quanta") is a cutting-edge technology platform whose patented, proprietary technology harnesses advances in quantum biology to increase the potency of active ingredients. Currently, Quanta supports product formulations in pain management, anti-inflammation, skincare, anti-aging, nutritional supplements, and plant-based consumables. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste and facilitate healthier, more sustainable consumption.

The established resonance theory behind Quanta's polarization process has many potential applications. From potentiating bio-ingredients to produce more-effective carbon-trapping plants to transformative anti-aging solutions Quanta's technology has the opportunity to upend how commercial products are made and the benefits from them. Already we see multi-trillion-dollar global industries benefiting from Quanta's technology. You can find more about Quanta at https://buyquanta.com/.

About moleque: https://molequleskincare.com/

Contacts:

Darrow Associates, Inc.
Peter Seltzberg, Managing Director, IR
pseltzberg@darrowir.com
(516) 419-9915

SOURCE: Quanta

ReleaseID: 595171

VANCOUVER, BC / ACCESSWIRE / June 25, 2020 / Granite Creek Copper Ltd. (TSXV:GCX) ("Granite Creek" or "the Company") announces the receipt of a ten-year Class 4 exploration permit for physical work on the Company's Stu Copper-Gold Project ("the Permit") in the Yukon's Minto Copper District, and the mobilization of field exploration crews.

The Permit, which covers approximately 68 square kilometres, including the priority A and B zones, allows for up to 100,000 meters of diamond drilling and 60,000 meters of RC drilling, in addition to trenching, road construction and upgrading. This new permit, together with an existing permit over the southern part of the property, means that over 95% of the Company's claims are permitted for exploration activities (see Figure 1 below).

Tim Johnson, President and CEO of Granite Creek Copper, stated, "Receipt of this permit covering the northern part of the Stu property including the A and B zones is an important milestone for the Company as it gives us the ability to maximize the efficiency of our programs for this year and subsequent years by enabling our teams to immediately work on our highest priority target areas. We are excited to review the internal geological model and use that model to drive future programs as we uncover new information from across the property."

Figure 1 – Permit outline, target areas, and high-grade mineralized zones

2020 Field Exploration Program

Granite Creek has begun mobilising crews to undertake a field program that will consist of re-sampling of historic core, multi-element soil sampling to determine the precious metal response in soils, and identifying drill sites for a follow up diamond drilling campaign, potentially later in the 2020 season.

Prior operators selectively sampled 20-30% of the core from the highly prospective Zone A using an in-house lab and very high precious metals detection limits based on the technology available at the time, resulting in incomplete information. (See selected drill intercept table below). As part of internal 3D modeling and review of historic drilling, Granite Creek has outlined a core re-sampling program that will include full multi-element analysis with industry standard detection limits for base and precious metals in order to ensure the proper, accurate inclusion of the full suite in core assays. In addition to assays, other core measurements such as magnetic susceptibility and spectral analysis will be taken to assist with alteration mapping and identification of other prospective areas of the property. The program is designed to provide a primary data set to be used to advance the area of historic drilling towards a formal National Instrument 43-101 compliant resource and assist in drill targeting efforts to qualify and expand the same.

Table 1 – Highlight Drill and Trench Results

Hole

from

To

Length**

Cu %

Au g/t ***

Ag g/t

Cu Eq %*

Au Eq %*

80-08

45.17

59.44

14.26

0.27

trace

1.95

80-09

41.15

60.96

19.81

2.52

1.64

12.84

3.1

4.77

Incl

47.24

60.96

13.72

3.44

2.10

14.71

5.36

6.35

80-11

183.79

192.63

8.84

0.27

Trace

0.83

80-11

195.38

199.58

4.21

0.58

Trace

trace

80-12

140.51

152.25

11.73

0.48

Trace

10.76

0.60

80-14

13.35

34.44

21.09

2.39

2.00

13.27

4.22

4.99

Incl

22.25

34.44

12.19

3.87

3.09

22.71

6.72

7.94

80-14

85.40

91.62

6.22

0.31

Trace

2.57

80-14

94.18

117.96

23.77

0.25

Trace

1.02

80-15

18.59

32.61

14.02

0.24

Trace

trace

80-15

81.29

93.57

12.28

0.24

Trace

0.52

80-15

169.96

187.45

17.50

0.49

Not assayed

6.43

80-16

46.02

64.31

18.29

0.41

Trace

2.46

80-16

184.22

199.55

15.33

0.40

Trace

0.70

80-16

217.02

232.56

15.45

0.47

Trace

1.02

80-18

53.16

79.07

25.91

1.65

2.36

12.06

3.77

4.46

Incl

66.75

79.07

12.31

2.85

4.28

24.50

6.47

7.95

80-20

38.13

54.86

16.73

0.32

Trace

0.56

*Total Copper Equivalent calculations reflect total gross metal content using metals prices as follows (all USD): $2.50/lb copper (Cu), 18.00/oz silver (Ag), and $1,450/oz gold (Au) and . Values have not been adjusted to reflect metallurgical recoveries. Total metal equivalent values include both base and precious metals. In terms of dollar value, 0.25% copper equates to a gold value of 0.30 g/t gold or a silver value of 23.81 g/t, using the above metal values.

**Widths are composite samples from drilled intercepts and the true thickness is unknown.

*** Completed in 1980 at an previous operator's lab using a higher than is typical for modern labs, lower detection limit for Au

Trench **

From

To

Length *

Cu %

Au g/t

Ag g/t

2015-800W

0

10.8

10.8

0.33

0.17

1.71

600W

64.30

80.00

15.7

0.22

0.04

0.91

14-01

0

6.0

6.0

0.55

0.27

1.90

14-02

1.5

5.0

3.5

0.49

0.33

2.23

14-04

0

4.0

4.0

0.36

0.16

1.32

* Widths are composites of surface samples and the true thickness is unknown

** Completed between 2014-2015 using modern multi-element ICP using a standard lower detection limit for Au.

About the Stu Copper-Gold Project

The Stu Copper-Gold project is part of the Minto Copper Belt, a linear stretch of intrusion hosted Cu-Au-Ag mineralization in the Dawson Range, south-central Yukon Territory. Centered on the Minto Mine the belt extends from north of the Yukon/Pelly River confluence southeast to the community of Carmacks. The Minto Copper Belt has been proven productive, with one operating copper mine and one deposit advancing towards production. The Stu property lies on strike between the two deposits, displays the same styles of mineralization, and has shown preliminary copper values of a similar calibre. To date the Company has identified 4 multi-kilometre exploration targets (see figure 1).

Copper, gold, and silver mineralization is contained in foliated to gneissic granodiorite (see Figure 2 below for Zone A geology), hosted within a large granodiorite intrusion. Historic drilling at Zone A in the centre of the property returned copper grades of 2.4 to 3.4% over 14 to 20 m widths in drill core from higher-grade mineralized zones dominated by copper sulphide (chalcopyrite, bornite and lesser copper oxide) mineralization. Mineralization has been confirmed as deep as 380 m below surface. Surface grades from trenches and upper levels of drill holes range from 0.18% to 0.55% Cu over widths of up to 20.0 m. Shallower mineralization is dominated by copper oxides (malachite, tenorite and azurite) with the underlying sulfide mineralization typically returning higher grades.

Figure 2 – Zone A detail

Live Webinar – July 2, 2020

Granite Creek Copper will be hosting a live webinar on Thursday, July 2 to discuss the most recent developments with the Company and the 2020 exploration season. Click here to register or contact us at info@gcxcopper.com.

Canadian Mining Symposium Replay

Granite Creek participated in the recent Canadian Mining Symposium hosted by The Northern Miner. An archived recording of our video presentation and follow-up Q&A with President & CEO, Tim Johnson, is available on the Metallic Group YouTube Channel.

About Granite Creek Copper

Granite Creek Copper is a Canadian exploration company focused on the advancement of its 100%-owned Stu Copper-Gold project located in the Yukon's Minto Copper District. This 115-square-kilometer property is on trend with Pembridge Resources' high-grade Minto Copper-Gold Mine to the north and the Carmacks Copper-Gold-Silver project to the south The Stu project has excellent access to infrastructure with the nearby paved Yukon Highway 2, along with grid power within 12 km. More information about Granite Creek and the Stu Copper-Gold Project can be viewed on the Company's website at www.gcxcopper.com.

About the Metallic Group of Companies

The Metallic Group is a collaboration of leading precious and base metals exploration companies, with a portfolio of large, brownfields assets in established mining districts adjacent to some of the industry's highest-grade producers of platinum & palladium, silver and copper. Member companies include Granite Creek Copper in the Yukon's Minto copper district, Metallic Minerals in the Yukon's Keno Hill silver district and Group Ten Metals in the Stillwater PGM-Ni-Cu district of Montana. The founders and team members of the Metallic Group include highly successful explorationists formerly with some of the industry's leading explorer/developers and major producers and are undertaking a systematic approach to exploration using new models and technologies to facilitate discoveries in these proven historic mining districts. The Metallic Group is headquartered in Vancouver, BC, Canada and its member companies are listed on the Toronto Venture, US OTC, and Frankfurt stock exchanges.

FOR FURTHER INFORMATION PLEASE CONTACT:

Timothy Johnson, President & CEO
Telephone: 1 (604) 235-1982
Toll Free: 1 (888) 361-3494
E-mail: info@gcxcopper.com
Website: www.gcxcopper.com

Quality Control and Quality Assurance

Ms. Debbie James, P.Geo., a qualified person for the purposes of National Instrument 43-101, has reviewed and approved the technical disclosure contained in this news release.

Forward-Looking Statements

Forward Looking Statements: This news release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts including, without limitation, statements regarding potential mineralization, historic production, estimation of mineral resources, the realization of mineral resource estimates, interpretation of prior exploration and potential exploration results, the timing and success of exploration activities generally, the timing and results of future resource estimates, permitting time lines, metal prices and currency exchange rates, availability of capital, government regulation of exploration operations, environmental risks, reclamation, title, and future plans and objectives of the company are forward-looking statements that involve various risks and uncertainties. Although Granite Creek Copper believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Forward-looking statements are based on a number of material factors and assumptions. Factors that could cause actual results to differ materially from those in forward-looking statements include failure to obtain necessary approvals, unsuccessful exploration results, changes in project parameters as plans continue to be refined, results of future resource estimates, future metal prices, availability of capital and financing on acceptable terms, general economic, market or business conditions, risks associated with regulatory changes, defects in title, availability of personnel, materials and equipment on a timely basis, accidents or equipment breakdowns, uninsured risks, delays in receiving government approvals, unanticipated environmental impacts on operations and costs to remedy same, and other exploration or other risks detailed herein and from time to time in the filings made by the companies with securities regulators. Readers are cautioned that mineral resources that are not mineral reserves do not have demonstrated economic viability. Mineral exploration and development of mines is an inherently risky business. Accordingly, the actual events may differ materially from those projected in the forward-looking statements. For more information on Granite Creek Copper and the risks and challenges of their businesses, investors should review their annual filings that are available at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Granite Creek Copper Ltd.

ReleaseID: 595195

Mr. Centala brings over 20 years of experience in strategic planning, product to market execution and business acceleration experience.

SAN DIEGO, CA / ACCESSWIRE / June 25, 2020 / VIRATECH CORP (OTC PINK:VIRA) a holding company acquiring and building consumer product companies that focuses on enhancing people's lifestyle through innovative products, health, nutrition and wellness, is pleased to announce the addition of John Centala to the management team as Chief Strategy Advisor.

Mr. Centala will assist in developing a strategic road map for new acquisitions, brand development, product innovation, private brands, supply chain optimization, and product path to market to expand distribution. This will also include working with CEO, Henry Manayan in evaluating potential M&A opportunities.

Mr. Centala has spent his career pioneering consumer product goods and as a senior retail executive with several Fortune 100 companies including 7-Eleven, Daymon Worldwide & Fleming Foods, helping to transform business processes and capabilities to maximize potential and accelerate enterprise shareholder value. Prior to joining VIRA, Mr. Centala was a Senior Director for 7-Eleven, Dallas, Texas where over his 11 year tenure he led several departments including Strategic Merchandising Optimization, Logistics and Demand Chain and Private Brands. He built and directed teams to help drive top-line sales growth and optimize margin for both U.S. and Canada. Prior to 7-Eleven Mr. Centala was Lead Director for Daymon Worldwide where he developed over 300 Private Brands items that exceeded $150 million in sales.

"We are excited to welcome Mr. Centala to our leadership team", CEO, Henry Manayan said. "As we expand operations and new product launches, we were actively seeking an individual with both consumer product development and go-to-market experience. Mr. Centala's experience and proven track record are ideal for our Chief Strategy Advisor position and exceeded our expectations. We have already begun creating a new strategic road map for product rollout to enhance the operations of our subsidiaries and look forward to providing further updates as we refine strategies and execution."

Mr. Centala stated; "I am excited about the opportunity with VIRA, and look forward to working with the team to add value and accelerate results. My goal will be to assist Mr. Manayan to set strategy, implement product, brand, and sales plans that clearly communicate product value, creating a path to market plan, and accelerating topline revenue growth getting these products into retail outlets. Throughout my career, I have been known as an innovator who empowers organizations and I look forward to helping VIRA optimize these opportunities and creating long term enterprise shareholder value."

Please visit our subsidiaries websites:

Cambridge Golfing
www.cambridgegolfing.com

Medori
www.medoriwellness.com

My Body Symphony
www.mybodysymphony.com

SOCIAL MEDIA:

Facebook

Cambridge Golfing

Medori Wellness

MyBodySymphony

Instagram

Cambridgegolf360

Medoricbd

Mybodysymphony

About VIRATECH CORP:

Viratech Corp. is a publicly-traded holding company (OTC: VIRA) focused on acquisitions in health, wellness, and nutrition with operations in San Diego, CA, Atlanta, GA, and Florida. Viratech subsidiaries include; Cambridge Golf, LLC, a company that designs and manufactures innovative sporting goods, clothing, supplements, CBD/hemp products and accessories to the sports, nutrition and golf markets; Medori Wellness producing the highest quality and purest CBD products to improve the lifestyle and well being of its customers and My Body Symphony a company developing, producing and marketing healthy, organic, plant-based products that can and will make a difference in people's lives. Viratech will continue to foster organic growth within its current holdings as well as grow through strategic acquisitions. Information on all Viratech holdings is available through the Cambridge Golf website. www.cambridgegolfing.com.

Safe Harbor: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact Information:

Henry Manayan, President/CEO
Henry@cambridgegolfing.com

SOURCE: Viratech Corp.

ReleaseID: 595118

Initial Order Anticipated to Lead to Additional Business with Other Product Lines for the Client

ROCHESTER, NY / ACCESSWIRE / June 25, 2020 / VerifyMe, Inc. (NASDAQ:VRME), a digital technology solutions provider specializing in counterfeit prevention, authentication, serialization, data mining, track and trace, features for labels, packaging and products, is pleased to announce its first VeriPASTM track and trace technology purchase order in the cannabis industry.

VerifyMe Chief Executive Officer, Patrick White, commented, "The cannabis industry represents a great opportunity for VerifyMe. According to an April 2020 market research study by BDSA and Arcview Market Research, the industry is expected to continue to be one of the fastest-growing global markets over the next five years, from growth of 46% to $14.8 billion in 2019 to an expected $47 billion by 2025. The emerging legal cannabis and vape industry is susceptible to black market counterfeits, as demonstrated by the U.S. vape crisis in September 2019."

While this initial order for pre-printed tamper-proof labels containing VeriPASTM technology is for one product, if the results from this initial order are positive, VerifyMe anticipates receiving multiple orders for this product over the year. This cannabis company has multiple products that could utilize the VeriPASTM technology which could be added in future orders once results from this initial order are analyzed.

Mr. White, continued, "This new order in cannabis, a new sector for us, demonstrates that our technology is applicable across a wide range of industries, where brand protection, authentication and anti-counterfeit technology has become increasingly important. Our initial order exemplifies our strategy of land and expand, as there are additional product opportunities for expansion with this new client. We look forward to working with this new customer in differentiating and adding value to their products."

VerifyMe's VeriPASTM track and trace will be utilized on pre-printed tamper-proof labels in order for the client to protect itself from counterfeit products containing contaminants. VeriPASTM allows customers to instantly authenticate the product with their smartphone before using the product thereby assuring the customer that the product is authentic before use.

The track and trace technology solution and the VeriPASTM web portal gives the brand owner the ability to monitor, control, protect and market the product during its whole life cycle from raw material to shipping to the warehouse to retail to finally, the customer. It enables track and trace of the product within 10 feet using a web portal that monitors the GPS locations. VeriPASTM will send warnings and pinpoint locations to the brand owner if it suspects any counterfeit or product diversion activity.

In addition, VeriPASTM empowers the brand owner to engage with the customer with one-on-one advertising with discounts, coupons, product specifications and provision of product details. VeriPASTM is also useful to the brand owner for data mining and gathering business intelligence.

We believe VeriPASTM solves an emerging significant problem of brand owners being bombarded with refunds and replacements of previously purchased counterfeit products. The brand owners can now verify the authenticity of any returned product.

About VerifyMe, Inc.

VerifyMe, Inc. (NASDAQ:VRME), is a technology solutions company that markets products supported by patents, patent applications and trade secrets which provides identifiers and serialization for authenticating, tracking and tracing functions for labels, packaging and products. VerifyMe's technology authenticates packaging, labels and documents with a suite of proprietary security inks and pigments, which work in conjunction with serialization and track-and-trace software known as VeriPAS™ that allows both consumers and brand inspectors to verify authenticity with their smartphones. VeriPAS™ is a serialization software system that brand owners access through a web portal to monitor, control and protect their products complete life cycle. To learn more, visit www.verifyme.com

Cautionary Note Regarding Forward-looking Statements

This release contains forward-looking statements regarding revenue opportunities, the use of our products in additional presses and locations, the results of ongoing tests, and roll-out of our products and authentication devices which involve uncertainty and risk. The words "believe," "may", "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the company's ability to work with partners in selling its technologies to businesses, production difficulties, our inability to enter into contracts and deals with future partners, and issues which may affect the reluctance of large companies to change their purchasing of products, acceptance of our technologies, the efficiency of our authenticators in the field, our patents including potential litigation, and the ongoing novel COVID-19 pandemic. Further information on our risk factors is contained in our filings with the SEC, including the Form 10-K for the year ended December 31, 2019. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

For Licensing or Other Information Contact:
Company: VerifyMe, Inc.
Email: IR@verifyme.com
Website: http://www.verifyme.com

Investors:
ClearThink
nyc@clearthink.capital

SOURCE: VerifyMe

ReleaseID: 595158